HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With Ependymoma
Clinical trial NCT04903080 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04903080
- Sponsor
- Children's Oncology Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-27
- Primary completion
- 2033-03-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.